Humanitas Research Hospital
Rozzano, Milan, 20089, Italy
NCT Number: NCT02056041
Selection criteria for safe hepatectomy for HCC are not well established. The aim of this study was the validation of the selection criteria for safe hepatectomy for hepatocellular carcinoma.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Rozzano, Milan, 20089, Italy
All consecutive patients submitted to hepatectomy for HCC based on the same preoperative selection criteria from our prospectively-maintained liver unit database. Such criteria included the value of bilirubin (BIL), the value of cholinesterases (CHE), the presence of ascites, the presence of esophageal varices, and the rate of residual liver volume.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Liver surgery, Liver resection, Hepatic resection
Time frame: 90 days
The primary endpoint was the validation of our selection criteria for safe hepatectomy for HCC in regards to postoperative complications. The role of total bilirubin and cholinesterases was analzyed together with other clinical parameters.
Time frame: 90 days
The secondary endpoint was the testing of the most common score systems for HCC, which are the CPT score, the MELD score, and the APRI score.
University of Milan
Other
Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma: Validation on 336 Consecutive Hepatectomies.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07062380
Hepatecellular Carcinoma, Hepatectomy
Wuhan, Hubei, China
View Trial DetailsNCT01469442
Biliary Fistula, Digestive System Diseases
Clichy, France
View Trial DetailsNCT01950845
Colorectal Surgery, Hepatectomy
Pierre-Bénite, France
View Trial DetailsNCT06166186
Fractures, Bone, Fractures, Stress
Istanbul, Turkey (Türkiye)
View Trial Details